HIMS launches multi-cancer screening blood test through GRAIL partnership

Go back to HIMS launches multi-cancer screening blood test through GRAIL partnership
(NYSE: HIMS) Delayed: 30.51 -1.26 (3.97%)
Previous Close $31.77    52 Week High
Open $29.71    52 Week Low
Day High $31.79    P/E N/A 
Day Low $29.41    EPS
Volume 23,124,713